Annual report pursuant to Section 13 and 15(d)

STOCK WARRANTS AND STOCK OPTIONS (Details Narrative)

v3.20.1
STOCK WARRANTS AND STOCK OPTIONS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Oct. 27, 2019
Oct. 25, 2019
Oct. 24, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2012
Dec. 12, 2019
Dec. 31, 2017
Stock subscriptions payable     $ 79,624 $ 1,271      
Stock subscriptions payable, convertible amount, shares       2,962,688 243,273      
Related party gain (loss)   $ 39,992 $ 20,624      
Account payable       $ 213,880 $ 191,714      
Non Employee Stock Warrants [Member]                
Number of warrants outstanding       19,903,261 24,003,003      
Granted       30,485,423 7,882,392      
Fair value of detached free-standing stock warrants granted       $ 159,961 $ 29,701      
Gary Graham [Member]                
common stock acquire   $ 800,000            
Expected lives   5 years          
Exercise price per share $ 0.00792        
First Capital Ventures "FCV" [Member] | 8% Series A-1 Convertible Preferred Stock Investment agreement [Member]                
Number of warrants outstanding       4,800,000 0      
Convertible preferred stock shares sold       1,000,000        
Sale of stock price per share             $ 1.00  
Common stock shares issuable upon exercise of warrants to SPV             4,800,000  
Exercise price of warrants             $ 0.03125  
Michael A. Lanphere [Member]                
Number of warrants outstanding       15,103,261 10,818,583      
Michael A. Lanphere [Member] | Non employee stock options [Member]                
Expected lives           5 years    
Loan agreement description           The number of shares to be issued to Mr. Lanphere as a Stock Fee under each Agreement was an estimate and varied based on the loan amount and the price of our common stock on the day of the loan and was calculated by this formula: sixty percent (60%) of the loan amount divided by the Company’s stock price on the day of the loan, but at a price per share no higher than two and one-half cents ($0.025).    
David Gandini [Member]                
common stock acquire   $ 35,200,000          
Expected lives   10 years          
Exercise price per share $ 0.00792        
Option vesting terms   (i) 6,666,600 Pre-Vesting Option Shares representing the monthly vesting option shares for the ten months ended October 31, 2019 to vest on November 1, 2019; and (ii) the remaining 1,333,400 Pre-Vesting Option Shares representing the monthly vesting option shares for the two months ended December 31, 2019 shall vest on January 1, 2020.          
Installments period description   Stock options to vest in 36 equal monthly installments of 666,666 shares during the three-year term of the employment agreement.          
Option Vested   8,000,000   7,999,732        
Kevin Moore [Member]                
common stock acquire   $ 35,200,000            
Expected lives   3 years          
Exercise price per share $ 0.00792        
Installments period description   Stock options to vest in 36 equal monthly installments of 977,777 shares during the three-year term of the employment agreement.          
Option Vested       1,955,555        
Nick Noceti [Member]                
common stock acquire   $ 800,000            
Expected lives   5 years          
Exercise price per share $ 0.00792        
Charles Bennington [Member]                
common stock acquire   $ 800,000            
Expected lives   5 years          
Exercise price per share $ 0.00792        
2019 Equity Incentive Plan [Member]                
common stock acquire   $ 76,000,000        
Exercise price per share   $ 0.00792      
Common stock authorized shares       128,000,000        
Stock option vested shares       14,755,287        
Stock option non-vested shares       61,244,713        
Stock Options [Member]                
Description for outstanding stock options       These 250,000 outstanding executive stock options expired in October 2019.      
Account payable              
Number of warrants outstanding            
common stock acquire $ 3,200,000 $ 6,400,000            
Granted       79,200,000      
Stock options outstanding       1,775,000     2,225,000
Expected lives 5 years 2 years          
Options Exercised       76,000,000 250,000      
weighted average remaining contractual life       9 years        
Exercise price per share $ 0.03125 $ 0.00792   $ 0.00792 $ 0.007